MedPath

Early treatment of central serous retinopathy by photodynamic therapy. A randomized controlled trial.

Completed
Conditions
Central serous retinopathy.
Registration Number
NL-OMON20530
Lead Sponsor
Het Oogziekenhuis RotterdamSchiedamse Vest 180 3011 BH Rotterdam Nederland
Brief Summary

Missotten TOAR, Hoddenbach JG, Eenhorst CAE, van den Born LI, Martinez Ciriano JP, Wubbels RJ. A randomized clinical trial comparing prompt photodynamic therapy (PDT) with three months observation in patients with acute central serous chorioretinopathy (CSC) with central macular leakage, Eur J Ophthalmol, [Epub]. PMID: 32264706

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

1. Age > 18 years;

2. Informed consent;

Exclusion Criteria

1. History of CSR in either eye;

2. Allergy to fluorescein dyes;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath